Alkermes
ALKS
#3136
Rank
NZ$8.23 B
Marketcap
NZ$49.87
Share price
1.40%
Change (1 day)
-5.44%
Change (1 year)

Alkermes (ALKS) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$1.02 Billion

According to Alkermes's latest financial reports the company's total liabilities are NZ$1.02 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Alkermes - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$1.04 B-29.06%
2023-12-31NZ$1.47 B1.85%
2022-12-31NZ$1.44 B8.56%
2021-12-31NZ$1.33 B9.12%
2020-12-31NZ$1.22 B14.44%
2019-12-31NZ$1.06 B9.69%
2018-12-31NZ$0.97 B16.44%
2017-12-31NZ$0.83 B12.15%
2016-12-31NZ$0.74 B-5.67%
2015-12-31NZ$0.79 B18.7%
2014-12-31NZ$0.66 B
2013-03-31NZ$0.61 B-12.7%
2012-03-31NZ$0.70 B791.5%
2011-03-31NZ$79.44 M-45.4%
2010-03-31NZ$0.14 B-37.31%
2009-03-31NZ$0.23 B-46.84%
2008-03-31NZ$0.43 B-14.45%
2007-03-31NZ$0.51 B-30.43%
2006-03-31NZ$0.73 B55.88%
2005-03-31NZ$0.47 B61.83%
2004-03-31NZ$0.29 B-38.25%
2003-03-31NZ$0.47 B-17.21%
2002-03-31NZ$0.56 B-7%
2001-03-31NZ$0.61 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Acorda Therapeutics
ACOR
NZ$0.45 B-55.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$134.53 B 13,033.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$195.11 B 18,947.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$198.71 B 19,299.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$117.69 B 11,389.23%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$56.02 B 5,369.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Sanofi
SNY
NZ$113.46 B 10,976.89%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
NZ$107.46 B 10,391.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland